Multiple Myeloma and IV Bisphosphonate Are Risk Factors for Osteonecrosis of the Jaw

被引：0
|
作者：
Tennis, Pat [1 ]
Rothman, Kenneth J. [1 ]
Bohn, Rhonda [2 ]
Tan, Hiangkat [2 ]
Anthony, Mary [3 ]
Zavras, Athanosios [4 ]
Calingaert, Brian [1 ]
机构：
[1] RTI Hlth Solut, Res Triangle Pk, NC USA
[2] Healthcore Inc, Wilmington, DE USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
[4] Columbia Univ, New York, NY USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2010年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
741
引用
收藏
页码：S313 / S314
页数：2
相关论文
共 50 条
  • [1] Risk factors for bisphosphonate-related osteonecrosis of jaw in multiple myeloma patients
    Cafro, A. M.
    Babarano, L.
    Nichelatti, M.
    D'Avanzo, G.
    Gaglioti, D.
    Taroni, A.
    Riva, F.
    Nosari, A.
    Andriani, A.
    Morra, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 215 - 216
  • [2] Bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma
    Infante Cossio, Pedro
    Cabezas Macian, Antonio
    Perez Ceballos, Jose Luis
    Palomino Nicas, Julian
    Gutierrez Perez, Jose Luis
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2008, 13 (01): : E52 - E57
  • [3] Incidence and risk factors of bisphosphonate induced osteonecrosis of the jaw (BONJ) in patients with multiple myeloma after HDT and ASCT
    Hoerauf, N.
    Bumeder, I.
    Otto, S.
    Ebelt, K.
    Voelkl, A.
    Baumann, P.
    Schmidmaier, R.
    Alpay, N.
    Adam, C.
    Roehnisch, T.
    Oduncu, F. S.
    ONKOLOGIE, 2010, 33 : 245 - 245
  • [4] Novel risk factors for osteonecrosis of the jaw in multiple myeloma: A RADAR report
    Holbrook, Jaimee S.
    Trifilio, Steven M.
    Mckoy, June M.
    Singhal, Seema
    Rademaker, Alfred
    Mehta, Jayesh
    Belknap, Steven M.
    Tica, Stefani
    Clark, Sarah Victoria
    Godinez-Puig, Victoria
    Nardone, Beatrice
    Gradishar, William John
    West, Dennis P.
    Edwards, Beatrice J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Osteonecrosis of the jaw in multiple myeloma patients: Clinical features and risk factors
    Badros, A
    Weikel, D
    Salama, A
    Goloubeva, O
    Schneider, A
    Rapoport, A
    Fenton, R
    Gahres, N
    Sausville, E
    Ord, R
    Meiller, T
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) : 945 - 952
  • [6] Conservative Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients
    Melea, Pelagia I.
    Melakopoulos, Ioannis
    Kastritis, Efstathios
    Tesseromatis, Christina
    Margaritis, Vasileios
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    INTERNATIONAL JOURNAL OF DENTISTRY, 2014, 2014
  • [7] Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer
    Nastro, E.
    Musolino, C.
    Allegra, A.
    Oteri, G.
    Cicciu, M.
    Alonci, A.
    Quartarone, E.
    Alati, C.
    De Ponte, F. S.
    ACTA HAEMATOLOGICA, 2007, 117 (03) : 181 - 187
  • [8] Incidence and Risk Factors of Bisphosphonate-Related Osteonecrosis of the Jaw in Multiple Myeloma Patients Having Undergone Autologous Stem Cell Transplantation
    Then, Cornelia
    Hoerauf, Natalie
    Otto, Sven
    Pautke, Christoph
    von Tresckow, Emmo
    Roehnisch, Tim
    Baumann, Philipp
    Schmidmaier, Ralf
    Bumeder, Irmgard
    Oduncu, Fuat S.
    ONKOLOGIE, 2012, 35 (11): : 658 - 664
  • [9] Oral Health Risk Factors for Bisphosphonate-Associated Jaw Osteonecrosis
    Tsao, Claudine
    Darby, Ivan
    Ebeling, Peter R.
    Walsh, Katrina
    O'Brien-Simpson, Neil
    Reynolds, Eric
    Borromeo, Gelsomina
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2013, 71 (08) : 1360 - 1366
  • [10] Bisphosphonate related osteonecrosis of the jaw: Risk factors. A case report
    Elias, N. O.
    Young, P.
    Rella, N. G.
    Moran, M.
    Curria, M.
    BONE, 2017, 105 : 303 - 303
12345